|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV033962634 |
| 003 |
DE-627 |
| 005 |
20230624001934.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2014 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/S0378-3782(14)70026-X
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2014012000026.pica
|
| 035 |
|
|
|a (DE-627)ELV033962634
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(14)70026-X
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Kaufman, David A.
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety
|
| 264 |
|
1 |
|c 2014
|
| 300 |
|
|
|a 4
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Fluconazole prophylaxis has demonstrated efficacy in single and multicenter randomized controlled trials without side effects or emergence of resistance. Additional evidence based on incidence of invasive Candida infections, multicenter data, resistance, and safety is desired.
|
| 650 |
|
7 |
|a Antifungal
|2 Elsevier
|
| 650 |
|
7 |
|a Candida
|2 Elsevier
|
| 650 |
|
7 |
|a Preterm infants
|2 Elsevier
|
| 650 |
|
7 |
|a Safety
|2 Elsevier
|
| 650 |
|
7 |
|a Fluconazole prophylaxis
|2 Elsevier
|
| 700 |
1 |
|
|a Morris, Amy
|4 oth
|
| 700 |
1 |
|
|a Gurka, Matt J.
|4 oth
|
| 700 |
1 |
|
|a Kapik, Barry
|4 oth
|
| 700 |
1 |
|
|a Hetherington, Seth
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:90
|g year:2014
|g pages:87-90
|g extent:4
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/S0378-3782(14)70026-X
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 90
|j 2014
|h 87-90
|g 4
|y 90.2014, S87-, (4 S.)
|
| 953 |
|
|
|2 045F
|a 610
|